BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27578423)

  • 1. Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia.
    Haynes LD; Coonen J; Post J; Brunner K; Bloom D; Hematti P; Kaufman DB
    J Clin Apher; 2017 Oct; 32(5):288-294. PubMed ID: 27578423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three mobilization protocols for peripheral blood stem cell apheresis with Spectra Optia continuous mononuclear cell protocol in healthy dogs.
    Kim S; Hosoya K; Kobayashi A; Okumura M
    Vet Comp Oncol; 2019 Mar; 17(1):61-68. PubMed ID: 30221450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems.
    Brauninger S; Bialleck H; Thorausch K; Felt T; Seifried E; Bonig H
    Transfusion; 2012 May; 52(5):1137-45. PubMed ID: 22044384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial.
    Brauninger S; Bialleck H; Thorausch K; Seifried E; Bonig H
    Vox Sang; 2011 Oct; 101(3):237-46. PubMed ID: 21517897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection.
    Wu HL; Greene JM; Swanson T; Shriver-Munsch C; Armantrout K; Weber WC; Bateman KB; Maier NM; Northrup M; Legasse AW; Moats C; Axthelm MK; Smedley J; Maziarz RT; Martin LD; Hobbs T; Burwitz BJ; Sacha JB
    J Clin Apher; 2021 Feb; 36(1):67-77. PubMed ID: 32941672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ; Farese AM; Davis TA; Lind LB; McKearn JP
    Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection.
    Chung Y; Kong JH; Hu Y; Lee SN; Shim H; Eom HS; Kong SY
    J Clin Apher; 2021 Feb; 36(1):28-33. PubMed ID: 32882095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures.
    Sanderson F; Poullin P; Smith R; Nicolino-Brunet C; Philip P; Chaib A; Costello R
    J Clin Apher; 2017 Jun; 32(3):182-190. PubMed ID: 27442837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.
    Uchida N; Bonifacino A; Krouse AE; Metzger ME; Csako G; Lee-Stroka A; Fasano RM; Leitman SF; Mattapallil JJ; Hsieh MM; Tisdale JF; Donahue RE
    Exp Hematol; 2011 Jul; 39(7):795-805. PubMed ID: 21549175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.
    Lefrère F; Mauge L; Réa D; Ribeil JA; Dal Cortivo L; Brignier AC; Aoun C; Larghéro J; Cavazzana-Calvo M; Micléa JM
    Transfusion; 2013 Mar; 53(3):564-9. PubMed ID: 22725259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
    Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells-apheresis (HPC-a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study.
    Pandey S; Cottler-Fox M
    J Clin Apher; 2018 Aug; 33(4):505-513. PubMed ID: 29603795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis.
    Rowley SD; Yu J; Gooley T; Heimfeld S; Holmberg L; Maloney D; Bensinger WI
    Bone Marrow Transplant; 2001 Oct; 28(7):649-56. PubMed ID: 11704787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance.
    Sosa RA; Mone T; Naini BV; Kohn DB; Reed EF; Wheeler K; Campo-Fernandez B; Davila A; Chaffin DJ; DiNorcia J; Kaldas FM; Cohen A; Lum EL; Veale JL; Kogut NM
    Transplantation; 2023 Feb; 107(2):504-510. PubMed ID: 35974436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
    Brave M; Farrell A; Ching Lin S; Ocheltree T; Pope Miksinski S; Lee SL; Saber H; Fourie J; Tornoe C; Booth B; Yuan W; He K; Justice R; Pazdur R
    Oncology; 2010; 78(3-4):282-8. PubMed ID: 20530974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
    Pusic I; Jiang SY; Landua S; Uy GL; Rettig MP; Cashen AF; Westervelt P; Vij R; Abboud CN; Stockerl-Goldstein KE; Sempek DS; Smith AL; DiPersio JF
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1045-1056. PubMed ID: 18721768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.
    Ikeda K; Minakawa K; Muroi K; Fujiwara SI; Yamada-Fujiwara M; Fujimori Y; Tanosaki R; Ohto H;
    Transfusion; 2016 Nov; 56(11):2839-2847. PubMed ID: 27572290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.